Oct 03, 2024 / 05:15PM GMT
Operator
Good evening. Good evening, everyone, sorry. Welcome to this webinar focused on the presentation of Poxel's 2023 full-year results.
Before leaving the floor to Thomas Kuhn, CEO; Fanny Bosa, VP, Finance and Administration; and Tejdeep Bawa, VP Business Development, we would like to remind you that you have the possibility to ask your question to the management in writing through the question tab at the bottom right of your screen.
Thomas, the floor is yours.
Thomas Kuhn - Poxel SA - Chief Executive Officer, Director
Thank you, [Nicola]. Hello, everyone, and good afternoon and good evening. Thank you very much for attending the call. So we have several topics basically to cover today.
So first, we'll start with the presentation of our full-year 2023 financial results that have been just approved. And so Fanny will present that. We will then switch to and update you on the commercial dynamic for our lead product in diabetes, TWYMEEG, in Japan, which is then a good segue to, again, present you, following what we did last Monday, the
Full Year 2023 Poxel SA Earnings Call Transcript
Oct 03, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers